Page 3 - B Johnson News Today

The Biden administration said Friday it expects omicron to become the dominant strain of the coronavirus within weeks and predicted the fallout will divide into two paths, causing mild cases among vaccinated-and-boosted Americans while the unvaccinated confront a winter of misery and death.

The recently concluded Kyle Rittenhouse case is not the only reminder that prosecutors need to be carefully watched.

Recipients of the Johnson & Johnson COVID-19 vaccine were more likely to experience a rare blood clotting issue than persons in the general population before the pandemic, according to a study published Monday by JAMA Internal Medicine.

Recipients of the Johnson & Johnson COVID-19 vaccine were more likely to experience a rare blood clotting issue than persons in the general population before the pandemic, according to a study published Monday by JAMA Internal Medicine.

Drugmaker Moderna said Tuesday it will make up to 110 million doses of its COVID-19 vaccine available to the African Union as the company faces pressure to reach beyond wealthier countries.

Drugmaker Moderna said Tuesday it will make up to 110 million doses of its COVID-19 vaccine available to the African Union as the company faces pressure to reach beyond wealthier countries.

The Biden administration said Friday it is not changing its definition of what it means to be fully vaccinated against COVID-19, after the Centers for Disease Control and Prevention greatly expanded the range of people eligible for booster doses.

The Biden administration said Friday it is not changing its definition of what it means to be fully vaccinated against COVID-19, after the Centers for Disease Control and Prevention greatly expanded the range of people eligible for booster doses.

A booster of Pfizer-BioNTech's COVID-19 vaccine has proved highly effective in warding off disease from the dominant delta strain of the coronavirus, according to preliminary results of a late-stage trial.

A booster of Pfizer-BioNTech's COVID-19 vaccine has proved highly effective in warding off disease from the dominant delta strain of the coronavirus, according to preliminary results of a late-stage trial.